Chitooligosaccharides 2022
DOI: 10.1007/978-3-030-92806-3_9
|View full text |Cite
|
Sign up to set email alerts
|

Disease Preventing Bioactivities of Chitooligosaccharides: Current Status and Future Trends

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 82 publications
0
0
0
Order By: Relevance
“…CHOS possesses the reactive amino group at C-2 and hydroxyl groups at C-3 and C-6, which could favor chemical modification such as acylation, oxidation, etherification, graft copolymerization, cationization, phosphorylation, etc. [11], thus enhancing CHOS' bioactivities. CHOS derivatives have been used to alleviate metastasis and tumor growth [12,13] and increase bone strength by preventing osteoporosis [14][15][16].…”
Section: Introductionmentioning
confidence: 99%
“…CHOS possesses the reactive amino group at C-2 and hydroxyl groups at C-3 and C-6, which could favor chemical modification such as acylation, oxidation, etherification, graft copolymerization, cationization, phosphorylation, etc. [11], thus enhancing CHOS' bioactivities. CHOS derivatives have been used to alleviate metastasis and tumor growth [12,13] and increase bone strength by preventing osteoporosis [14][15][16].…”
Section: Introductionmentioning
confidence: 99%